ClinConnect ClinConnect Logo
Search / Trial NCT05549713

The Effect of Upper Blepharoplasty on Vision Quality in the Early Postoperative Period

Launched by OSIJEK UNIVERSITY HOSPITAL · Sep 13, 2022

Trial Information

Current as of July 04, 2025

Recruiting

Keywords

Corneal Topography Contrast Sensitivity Eyelid Disease Meibomian Gland Dysfunction Blepharoplasty

ClinConnect Summary

This clinical trial is studying the effects of upper blepharoplasty, a surgical procedure to remove excess skin from the upper eyelids, on vision quality shortly after the surgery. Researchers want to see if this procedure improves two key aspects of vision: contrast sensitivity (how well you can see differences in light and dark) and tear film quality (how well your eyes are lubricated). They will assess patients before the surgery and again one month after to understand how these factors may change.

To participate in this study, individuals must have functional dermatochalasis, which means they experience problems with their upper eyelids obstructing their vision, such as difficulty opening their eyes in the morning or headaches. However, those with certain eye conditions, like severe dry eyes or previous eye surgeries, will not be eligible. Participants can expect to undergo a detailed eye examination and have their vision and tear film quality tested before and after the surgery. This research aims to clarify the benefits of upper eyelid surgery on vision and help find the best techniques for improving patients' quality of life.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients with functional dermatochalasis on the upper eyelid with subjective difficulties due to obstructing the upper part of visual field: swelling of the eyelids in the morning with difficulties in opening the eyes, use of the frontal musculature to be able to have at least a partial width of the field of vision in the upper part that is adequate for daily functioning, and headaches.
  • Exclusion Criteria:
  • History of corneal refractive surgery, pterygium, glaucoma, nuclear sclerosis \> 4th degree, severe dry eye, age-related macular degeneration, neuro-ophthalmological diseases, use of hormone therapy, diabetic retinopathy or condition after panretinal photocoagulation. Corneal pathologies such as keratoconus and gross eyelid malposition conditions such as entropion, ectropion and marked laxity of the eyelids are also grounds for exclusion from the study.

About Osijek University Hospital

Osijek University Hospital is a leading healthcare institution dedicated to advancing medical research and patient care. Located in Osijek, Croatia, the hospital integrates clinical practice with academic excellence, fostering a collaborative environment for healthcare professionals and researchers. With a commitment to innovation, Osijek University Hospital actively sponsors clinical trials aimed at evaluating new therapies and improving treatment outcomes across various medical fields. By leveraging state-of-the-art facilities and a multidisciplinary team, the hospital plays a pivotal role in contributing to the advancement of medical knowledge and enhancing the quality of life for patients.

Locations

Osijek, , Croatia

Patients applied

0 patients applied

Trial Officials

Dunja Bajtl

Principal Investigator

Osijek University Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials